(Q81661613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

main subject

cost–benefit analysis

1 reference

Goldman GS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

3349-3355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

The cost-effectiveness of routine childhood varicella vaccination in Germany

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Economic evaluation of vaccination programs: the impact of herd-immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Costs And Benefits Of Routine Varicella Vaccination In German Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Instituting a routine varicella vaccination program in Canada: an economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Epidemiologic effects of varicella vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Childhood vaccination against chickenpox: an analysis of benefits and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Do the benefits of varicella vaccination outweigh the long-term risks? A decision-analytic model for policymakers and pediatricians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

The cost-effectiveness of varicella vaccine programs for Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Economic evaluations of varicella vaccination programmes: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

The cost-effectiveness of varicella vaccination in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Immunologic Evidence of Reinfection with Varicella-Zoster Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Lasting immunity to varicella in doctors study (L.I.V.I.D. study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Incidence of Herpes Zoster in Pediatricians and History of Reexposure to Varicella-zoster Virus in Patients with Herpes Zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

The incidence of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Immunization to reduce the frequency and severity of herpes zoster and its complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Varicella susceptibility and incidence of herpes zoster among children and adolescents in a community under active surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Vaccine safety: current and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Modelling the impact of immunization on the epidemiology of varicella zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Prevalence of antibodies to four herpesviruses among adults with glioma and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

Varicella vaccine and shingles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

American grandparents providing extensive child care to their grandchildren: prevalence and profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.042

10.1016/J.VACCINE.2003.10.042

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837242%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference